Acyl-Coenzyme A–Binding Protein Regulates Beta-Oxidation Required for Growth and Survival of Non–Small Cell Lung Cancer

We identified acyl-coenzyme A–binding protein (ACBP) as part of a proteomic signature predicting the risk of having lung cancer. Because ACBP is known to regulate β-oxidation, which in turn controls cellular proliferation, we hypothesized that ACBP contributes to regulation of cellular proliferation and survival of non–small cell lung cancer (NSCLC) by modulating β-oxidation. We used matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) and immunohistochemistry (IHC) to confirm the tissue localization of ABCP in pre-invasive and invasive NSCLCs. We correlated ACBP gene expression levels in NSCLCs with clinical outcomes. In loss-of-function studies, we tested the effect of the downregulation of ACBP on cellular proliferation and apoptosis in normal bronchial and NSCLC cell lines. Using tritiated-palmitate (3H-palmitate), we measured β-oxidation levels and tested the effect of etomoxir, a β-oxidation inhibitor, on proliferation and apoptosis. MALDI-IMS and IHC analysis confirmed that ACBP is overexpressed in pre-invasive and invasive lung cancers. High ACBP gene expression levels in NSCLCs correlated with worse survival (HR = 1.73). We observed a 40% decrease in β-oxidation and concordant decreases in proliferation and increases in apoptosis in ACBP-depleted NSCLC cells as compared with bronchial airway epithelial cells. Inhibition of β-oxidation by etomoxir in ACBP-overexpressing cells produced dose-dependent decrease in proliferation and increase in apoptosis (P = 0.01 and P < 0.001, respectively). These data suggest a role for ACBP in controlling lung cancer progression by regulating β-oxidation. Cancer Prev Res; 7(7); 748–57. ©2014 AACR.

[1]  K. Kristiansen,et al.  Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis. , 1994, The Biochemical journal.

[2]  F. Kuhajda,et al.  Fatty acid synthase and cancer: new application of an old pathway. , 2006, Cancer research.

[3]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[4]  H. Fujii,et al.  Expression of Liver-Type Fatty-Acid-Binding Protein, Fatty Acid Synthase and Vascular Endothelial Growth Factor in Human Lung Carcinoma , 2005, Pathobiology.

[5]  K. Kristiansen,et al.  Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation. , 1991, The Biochemical journal.

[6]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[7]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Moskaluk,et al.  Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy. , 2009, The American journal of pathology.

[9]  K. Kaluarachchi,et al.  Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. , 2010, The Journal of clinical investigation.

[10]  Min Wu,et al.  Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. , 2011, Biochimica et biophysica acta.

[11]  Kiweon Cha,et al.  Microarray analysis of differentially expressed genes associated with human ovarian cancer. , 2004, International journal of oncology.

[12]  R. Caprioli,et al.  Lung cancer diagnosis from proteomic analysis of preinvasive lesions. , 2011, Cancer research.

[13]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[14]  S. Haj-Dahmane,et al.  Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs , 2012, PloS one.

[15]  A. Chmurzyńska.  The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism , 2010, Journal of Applied Genetics.

[16]  G. Todaro,et al.  Isolation and characterization of a putative endogenous benzodiazepineoid (endozepine) from bovine and human brain. , 1986, The Journal of biological chemistry.

[17]  Gregory P Tochtrop,et al.  Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. , 2013, Cancer research.

[18]  F. Spener,et al.  A novel acyl-CoA-binding protein from bovine liver. Effect on fatty acid synthesis. , 1987, The Biochemical journal.

[19]  P. Selby,et al.  Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs. , 1989, Trends in pharmacological sciences.

[20]  J. Knudsen,et al.  Characterization of ligand binding to acyl-CoA-binding protein. , 1993, The Biochemical journal.

[21]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of a rat brain protein (GABA-modulin). , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Yasushi Noguchi,et al.  Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. , 2014, Metabolism: clinical and experimental.

[23]  P. Massion,et al.  Integrative Genomics Analysis Identifies Candidate Drivers at 3q26-29 Amplicon in Squamous Cell Carcinoma of the Lung , 2013, Clinical Cancer Research.

[24]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[25]  K. Yanagibashi,et al.  The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. , 1988, Endocrinology.

[26]  J. Swinnen,et al.  Increased lipogenesis in cancer cells: new players, novel targets , 2006, Current opinion in clinical nutrition and metabolic care.

[27]  Y. Liu,et al.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer , 2006, Prostate Cancer and Prostatic Diseases.

[28]  P. Massion,et al.  SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival , 2012, Clinical Cancer Research.

[29]  Jan Budczies,et al.  Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer , 2013, PloS one.

[30]  J. Menéndez,et al.  Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells , 2006, Current opinion in clinical nutrition and metabolic care.

[31]  J. Knudsen,et al.  The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase I. , 2001, The international journal of biochemistry & cell biology.

[32]  E. Cadenas,et al.  Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. , 2014, American journal of respiratory cell and molecular biology.

[33]  G. Todaro,et al.  Complete amino acid sequences of bovine and human endozepines. Homology with rat diazepam binding inhibitor. , 1986, The Journal of biological chemistry.

[34]  T D Lee,et al.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Knudsen,et al.  Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. , 1990, The Biochemical journal.

[36]  Yu Shyr,et al.  Proteomic patterns of preinvasive bronchial lesions. , 2005, American journal of respiratory and critical care medicine.

[37]  P. Massion,et al.  Expression of focal adhesion kinase in small‐cell lung carcinoma , 2012, Cancer.

[38]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[39]  L. B. Chen,et al.  Mitochondrial membrane potential monitored by JC-1 dye. , 1995, Methods in enzymology.

[40]  D. Petersen,et al.  The human fatty acid-binding protein family: Evolutionary divergences and functions , 2011, Human Genomics.

[41]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[42]  J. Menéndez,et al.  Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. , 2004, Archivum immunologiae et therapiae experimentalis.

[43]  B. Faubert,et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.

[44]  B. Persson,et al.  Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. , 1988, European journal of biochemistry.

[45]  A. Guidotti,et al.  Isolation, purification and partial sequence of a neuropeptide (diazepam-binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site , 1984, Neuroscience Letters.

[46]  K. Kristiansen,et al.  The function of acyl-CoA-binding protein (ACBP)/Diazepam binding inhibitor (DBI) , 1993, Molecular and Cellular Biochemistry.

[47]  F. Kuhajda.  Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. , 2000, Nutrition.

[48]  Richard M Caprioli,et al.  New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. , 2006, Journal of proteome research.